These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6547538)

  • 1. Specific sequestering agents for the actinides: 10. Enhancement of 238Pu elimination from mice by poly(catechoylamide) ligands.
    Durbin PW; Jeung N; Jones ES; Weitl FL; Raymond KN
    Radiat Res; 1984 Jul; 99(1):85-105. PubMed ID: 6547538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S).
    Lloyd RD; Bruenger FW; Mays CW; Atherton DR; Jones CW; Taylor GN; Stevens W; Durbin PW; Jeung N; Jones ES
    Radiat Res; 1984 Jul; 99(1):106-28. PubMed ID: 6547537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelation of 238Pu(IV) in vivo by 3,4,3-LICAM(C): effects of ligand methylation and pH.
    Durbin PW; White DL; Jeung NL; Weitl FL; Uhlir LC; Jones ES; Bruenger FW; Raymond KN
    Health Phys; 1989 Jun; 56(6):839-55. PubMed ID: 2722507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice.
    Volf V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):449-62. PubMed ID: 3485592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorporation of Pu and Am from beagles with delayed daily injections of 3,4,3-LICAM(C) or Zn-DTPA.
    Mays CW; Lloyd RD; Jones CW; Bruenger FW; Taylor GN; Durbin PW; White D; Raymond KN
    Health Phys; 1986 Apr; 50(4):530-4. PubMed ID: 3754241
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific sequestering agents for the actinides. 4. Removal of 238Pu(IV) from mice by sulfonated tetrameric catechoyl amides.
    Durbin PW; Jones ES; Raymond KN; Weitl FL
    Radiat Res; 1980 Feb; 81(2):170-87. PubMed ID: 6444746
    [No Abstract]   [Full Text] [Related]  

  • 7. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
    Durbin PW; Kullgren B; Jeung N; Xu J; Rodgers SJ; Raymond KN
    Hum Exp Toxicol; 1996 Apr; 15(4):352-60. PubMed ID: 8845226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
    Uhlir LC; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion by tetrameric catechoylamide ligands and CaNa3-DTPA of the dissociation in vitro of the Pu-transferrin complex formed after intravenous injection of Pu-tri-N-butylphosphate.
    Metivier H; Masse R; Durbin PW; Raymond KN
    Health Phys; 1985 Dec; 49(6):1302-5. PubMed ID: 3841100
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacies of LICAM(C) and DTPA for the decorporation of inhaled transportable forms of plutonium and americium from the rat.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
    Hum Toxicol; 1986 Mar; 5(2):77-84. PubMed ID: 3514430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacies of pure LICAM(C) and DTPA on the retention of plutonium-238 and americium-241 in rats after their inhalation as nitrate and intravenous injection as citrate.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A; Volf V; Taylor DM; Wirth P; Gaskin PW
    Int J Radiat Biol; 1989 Oct; 56(4):503-14. PubMed ID: 2571662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: comparison with rat, dog, and reference man.
    Durbin PW; Kullgren B; Schmidt CT
    Health Phys; 1997 Feb; 72(2):222-35. PubMed ID: 9003707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of 239Pu from mice with 3,4,3 LICAM(C) or N,N',N'',N'''-tetra-(2,3-dihydroxybenzoyl)-spermine.
    Szot Z; Rochalska M; Wojewódzka M; Chimiak A; Przychodzen W
    Radiat Environ Biophys; 1986; 25(1):31-5. PubMed ID: 3754971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
    Durbin PW
    Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
    Xu J; Kullgren B; Durbin PW; Raymond KN
    J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands.
    White DL; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1988 Jan; 31(1):11-8. PubMed ID: 2826783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacies of pure LICAM(C) and DTPA for enhancing the elimination of plutonium-238 and americium-241 from rats after their inhalation as nitrate.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
    Exp Pathol; 1989; 37(1-4):83-8. PubMed ID: 2637176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological behaviour of Pu administered to animals as Pu-standard LICAM(C) complex: therapeutical attempts to decrease Pu kidney burden.
    Gerasimo P; Duserre C; Metivier H
    Hum Toxicol; 1986 Sep; 5(5):309-18. PubMed ID: 3770768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Int J Radiat Biol; 2000 Feb; 76(2):199-214. PubMed ID: 10716641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.